OrbiMed Capital GP VII LLC

10% OwnerPassage BIO, Inc. (PASG) · full profile →Form 4 · filed Dec 6, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$77K
Net Open-Market Flow
-$77K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2024Sell(S)21K$0.82$17K7.7M
Dec 4, 2024Sell(S)76K$0.79$60K7.7M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-24-000995) within minutes of acceptance. Every field above traces to the original document. Verify it directly: